Latest News
Emcure Pharmaceuticals Limited
- Buy Emcure Pharmaceuticals; target of Rs 2330: Motilal Oswal
- Emcure Pharmaceuticals Share Price: Price Fall and Valuation
- Emcure Pharmaceuticals approves merger of two wholly-owned subsidiaries
- Emcure to fold two subsidiaries into parent in internal merger
- Emcure Pharma to Consolidate Operations by Merging Arms Zuventus, Emcutix
- Emcure Pharmaceuticals EMCURE Reg 74(5) Certificate Q2 FY27
- Emcure Pharmaceuticals Merges Two Wholly-Owned Subsidiaries
- Emcure Pharma to merge wholly owned units Zuventus, Emcutix with itself
- Emcure Pharma up over 3% as board approves merger of two subsidiaries
- Emcure Pharmaceuticals approves merger of two subsidiaries into parent entity
- Emcure Pharmaceuticals (NSEI:EMCURE) Stock Forecast & Analyst Predictions
- Emcure Pharmaceuticals - 5 midcap stocks see MF buying for 4 straight quarters; shares rally up to 98%
Headlines from the last 30 days, linking to the original publishers. See all market news →